Klaus D. Elgert

Biology Virginia Polytechnic Institute and State University, Blacksburg, VA, United States 
"Klaus Elgert"


Sign in to add mentor
James T Barrett grad student 1974 University of Missouri - Columbia


Sign in to add trainee
William L. Farrar grad student 1978 Virginia Tech (Cell Biology Tree)
Andrew D. Yurochko grad student 1990 Virginia Tech
David W. Mullins grad student 1993-1998 Virginia Tech
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Pressley JS, Elgert KD. (2006) Post-chemotherapeutic administration of interleukin-12 retards tumor growth and enhances immune cell function: combination therapy using paclitaxel and IL-12. Cancer Investigation. 24: 351-9
Mullins DW, Martins RS, Elgert KD. (2003) Tumor-derived cytokines dysregulate macrophage interferon-gamma responsiveness and interferon regulatory factor-8 expression. Experimental Biology and Medicine (Maywood, N.J.). 228: 270-7
Mullins DW, Martins RS, Burger CJ, et al. (2001) Tumor cell-derived TGF-beta and IL-10 dysregulate paclitaxel-induced macrophage activation. Journal of Leukocyte Biology. 69: 129-37
Mullins DW, Martins RS, Burger CJ, et al. (2001) Tumor cell-derived TGF-β and IL-10 dysregulate paclitaxel-induced macrophage activation Journal of Leukocyte Biology. 69: 129-137
Mullins DW, Burger CJ, Elgert KD. (1999) Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide. Journal of Immunology (Baltimore, Md. : 1950). 162: 6811-8
Mullins DW, Burger CJ, Elgert KD. (1998) Tumor growth modulates macrophage nitric oxide production following paclitaxel administration. International Journal of Immunopharmacology. 20: 537-51
Mullins DW, Koci MD, Burger CJ, et al. (1998) Interleukin-12 overcomes paclitaxel-mediated suppression of T-cell proliferation. Immunopharmacology and Immunotoxicology. 20: 473-92
Elgert KD, Alleva DG, Mullins DW. (1998) Tumor-induced immune dysfunction: the macrophage connection. Journal of Leukocyte Biology. 64: 275-90
Mullins DW, Walker TM, Burger CJ, et al. (1997) Taxol-mediated changes in fibrosarcoma-induced immune cell function: modulation of antitumor activities. Cancer Immunology, Immunotherapy : Cii. 45: 20-8
Mullins DW, Alleva DG, Burger CJ, et al. (1997) Taxol, a microtubule-stabilizing antineoplastic agent, differentially regulates normal and tumor-bearing host macrophage nitric oxide production. Immunopharmacology. 37: 63-73
See more...